Norepinephrine Administration Is Associated with Higher Mortality in Dialysis Requiring Acute Kidney Injury Patients with Septic Shock

Journal of Clinical Medicine
Ying-Ying ChenCAKS Group

Abstract

(1) Background: Norepinephrine (NE) is the first-line vasoactive agent used in septic shock patients; however, the effect of norepinephrine on dialysis-required septic acute kidney injury (AKI-D) patients is uncertain. (2) Methods: To evaluate the impact of NE on 90-day mortality and renal recovery in septic AKI-D patients, we enrolled patients in intensive care units from 30 hospitals in Taiwan. (3) Results: 372 patients were enrolled and were divided into norepinephrine users and non-users. After adjustment by Inverse probability of treatment weighted (IPTW), there was no significant difference of baseline comorbidities between the two groups. NE users had significantly higher 90-day mortality rate and using NE is a strong predictor of 90-day mortality in the multivariate Cox regression (HR = 1.497, p = 0.027) after adjustment. The generalized additive model disclosed norepinephrine alone exerted a dose⁻dependent effect on 90-day mortality, while other vasoactive agents were not. (4) Conclusion: Using norepinephrine in septic AKI-D patients is associated with higher 90-day mortality and the effect is dose-dependent. Further study to explore the potential mechanism is needed.

References

Aug 31, 2000·Critical Care Medicine·C MartinX Thirion
Aug 15, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Y S ChenS H Chu
Oct 12, 2001·JAMA : the Journal of the American Medical Association·F L FerreiraJ L Vincent
Nov 16, 2004·Critical Care Medicine·Jean-Louis Vincent, Herwig Gerlach
Aug 18, 2005·JAMA : the Journal of the American Medical Association·Shigehiko UchinoUNKNOWN Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators
Oct 11, 2005·Critical Care Medicine·Bruno LevyUNKNOWN College Interregional des Réanimateurs du Nord-Est
Aug 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Sean M BagshawUNKNOWN Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators
Aug 19, 2007·Intensive Care Medicine·Vin-Cent WuUNKNOWN National Taiwan University Surgical ICU Acute Renal Failure Study Group (NSARF)
Feb 29, 2008·The New England Journal of Medicine·James A RussellUNKNOWN VASST Investigators
Apr 12, 2008·Critical Care : the Official Journal of the Critical Care Forum·Sean M BagshawUNKNOWN ANZICS Database Management Committee
Jul 26, 2008·Intensive Care Medicine·John A MyburghUNKNOWN CAT Study investigators
Dec 31, 2008·Critical Care Medicine·Pedro R PóvoaUNKNOWN Portuguese Community-Acquired Sepsis Study Group
Jul 16, 2009·Critical Care Medicine·Charuhas V ThakarMarta L Render
Oct 2, 2009·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Michael G GaiesJennifer C Hirsch
Oct 21, 2009·Intensive Care Medicine·Anthony C GordonJeffrey J Presneill
Mar 5, 2010·The New England Journal of Medicine·Daniel De BackerUNKNOWN SOAP II Investigators
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
Apr 30, 2014·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Michael G GaiesRavi R Thiagarajan
Oct 8, 2014·Critical Care : the Official Journal of the Critical Care Forum·Lakhmir S ChawlaMichael G Seneff
Oct 16, 2014·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Maneesh KumarVijay Kher
Jul 15, 2015·Intensive Care Medicine·Eric A J HosteJohn A Kellum
Oct 16, 2015·BMC Emergency Medicine·Gilbert Abou DagherRalphe Bou Chebl
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Mervyn SingerDerek C Angus
Aug 3, 2016·JAMA : the Journal of the American Medical Association·Anthony C GordonUNKNOWN VANISH Investigators
Aug 23, 2016·Nephrology·Chih-Chung ShiaoUNKNOWN Taiwan Consortium for Acute Kidney Injury Renal Diseases (CAKs)
Nov 20, 2016·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Vin-Cent WuShih-Chieh Jeff Chueh
Jan 19, 2017·Critical Care Medicine·Andrew RhodesR Phillip Dellinger
May 10, 2017·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Amanda M McIntoshHalden F Scott
Jul 1, 2017·Journal of Hypertension·Vin-Cent WuUNKNOWN TAIPAI Study Group
Sep 14, 2017·JAMA : the Journal of the American Medical Association·Chanu RheeUNKNOWN CDC Prevention Epicenter Program

❮ Previous
Next ❯

Citations

Apr 17, 2020·Journal of Clinical Medicine·Charat ThongprayoonWisit Cheungpasitporn
Oct 23, 2019·Journal of Clinical Medicine·Vin-Cent WuTzong-Shinn Chu
Apr 4, 2021·Journal of Clinical Medicine·Emaad M Abdel-RahmanSamir C Gautam
Apr 13, 2021·Physiology International·G XantusP Kanizsai

❮ Previous
Next ❯

Methods Mentioned

BETA
GAM

Software Mentioned

R
MP
Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.